Adaptive Biotechnologies Corporation Profile Avatar - Palmy Investing

Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer …

Biotechnology
US, Seattle [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of ADPT's Analysis
CIK: 1478320 CUSIP: 00650F109 ISIN: US00650F1093 LEI: - UEI: -
Secondary Listings
ADPT has no secondary listings inside our databases.